The FDA has approved a new formulation of an F 18 prostate-specific membrane antigen imaging agent for men with prostate cancer, according to an industry press release.

BROOKLYN, NY / ACCESS Newswire / February 6, 2026 / IEH Corporation (OTC:IEHC) today filed with the Securities and ...

Ready to hear real experiences from current medical students? This virtual session is for you! In this live Q&A with current medical students at Mayo Clinic Alix School of Medicine, you'll have the ...

This table of contents is a navigational tool, processed from the headings within the legal text of Federal Register documents. This repetition of headings to form internal navigation links has no ...

What Are the Types of Health Insurance Plans? Health insurance companies offer multiple types of benefit designs, which affect where you can get care, how much you’ll pay and whether you need a ...

ACELYRIN, Inc., a Los Angeles area-based, late-stage clinical biopharma, with additional operations in the San Francisco Bay area, has announced it is acquiring privately held ValenzaBio – which ...

Linda McMaken has 15+ years of experience as a writer and editor. She is a published author and skilled blogger about consumer finance. Eric's career includes extensive work in both public and ...

Correspondence to Professor Yorck Olaf Schumacher, Aspetar Orthopaedic and Sports Medicine Hospital, Doha, Ad Dawhah, Qatar; yo.schumacher{at}aspetar.com Objective The Football World Cup is among the ...

LONDON — Two of the world’s biggest trading blocs are cautiously eyeing closer ties to short-circuit Donald Trump’s tariffs. The European Union and a 12-nation Indo-Pacific bloc are opening talks to ...